Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

clinical trial

Wikidata entity: Q64602743



Quantities

P4135maximum age45
P2899minimum age16
P1132number of participants586

P6099 clinical trial phase ... Q42824827 (phase III clinical trial) phase III clinical trial
P17 country ... Q16 (Canada) Canada
P17 country ... Q30 (United States) United States
P582 end time ... 2016-12-09 ???
P31 instance of ... Q30612 (clinical trial) clinical trial
P131 located in the administrative territorial entity ... Q1183 (Puerto Rico) Puerto Rico
P6153 research site ... Q50035610 (Precision Research Institute) Precision Research Institute
P6153 research site ... Q492318 (University of Alabama) University of Alabama
P6153 research site ... Q6806451 (Medical University of South Carolina) Medical University of South Carolina
P6153 research site ... Q7896167 (University of Puerto Rico, Río Piedras Campus) University of Puerto Rico, Río Piedras Campus
P6153 research site ... Q30269903 (Heartland Research Associates) Heartland Research Associates
P6153 research site ... Q30270033 (PMG Research) PMG Research
P6153 research site ... Q30282105 (Lynn Health Science Institute) Lynn Health Science Institute
P6153 research site ... Q30298472 (Radiant Research (United States)) Radiant Research (United States)
P580 start time ... 2014-10-13 ???
P8363 study type ... Q78089383 (interventional study) interventional study
P1476 title Monolingualtext A Phase 3, Double-blind, Multicentre, Randomised, Placebo-controlled Study to Determine the Efficacy and Safety of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis ???

External Ids
P3098ClinicalTrials.gov IDNCT02237950

Why not click here or view trends?

log id: 4248834